Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 17/20 | 0.78 |
| ▸ | EGFR | P00533 | 17/20 | 0.78 |
| ▸ | ABL1 | P00519 | 16/20 | 0.78 |
| ▸ | ABL2 | P42684 | 16/20 | 0.78 |
| ▸ | LCK | P06239 | 2/20 | 0.57 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.55 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7025034 | 0.95 | EGFR (0.75) | SRCEGFRABL1ABL2LCK | |
| SCHEMBL7023086 | 0.90 | SRC (0.76) | SRCEGFRABL1ABL2FGFR1 | |
| SCHEMBL7014659 | 0.90 | ABL1 (0.72) | SRCEGFRABL1ABL2LCK | |
| SCHEMBL7023438 | 0.89 | SRC (0.75) | SRCEGFRABL1ABL2 | |
| SCHEMBL8108111 | 0.87 | SRC (1.00) | SRCEGFRABL1ABL2LCK | |
| SCHEMBL7020683 | 0.85 | SRC (0.74) | SRCEGFRABL1ABL2LCK | |
| SCHEMBL8108104 | 0.85 | SRC (0.91) | SRCEGFRABL1ABL2LCK | |
| SCHEMBL7017527 | 0.85 | SRC (0.75) | SRCEGFRABL1ABL2 | |
| SCHEMBL7021401 | 0.85 | SRC (0.73) | SRCEGFRABL1ABL2 | |
| SCHEMBL7018931 | 0.85 | IGF1R (0.69) | SRCEGFRABL1ABL2LCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888353-B1 | N-7-HETEROCYCLYL PYRROLO [2,3-d]PYRIMIDINES AND THEIR USE | NOVARTIS AG (CH) | 2003-07-09 | — | — | EP | disclosed |